Faculty of Odontology, Malmö University, Malmö, Sweden.
Br Dent J. 2010 Feb 13;208(3):E5; discussion 114-5. doi: 10.1038/sj.bdj.2010.107. Epub 2010 Feb 5.
Almost all (17/20) Swedish counties have pharmaceutical committees that establish recommendations for the use of antibiotic prophylaxis in oral healthcare.Objective To evaluate the evidence for the use of antibiotic prophylaxis in oral healthcare and the agreement between Swedish recommendations and evidence.
We conducted a systematic literature search in PubMed and the Cochrane Controlled Trials Register. The MeSH terms 'antibiotic prophylaxis' and 'dentistry' were used in the database search. Abstracts were reviewed according to specific inclusion and exclusion criteria. A total of 186 articles were read in full text by the four authors independently. Data extraction and interpretation of data was carried out using a pre-defined protocol. In the end, one case-control study was included for evaluation of evidence.
The case-control study included patients with specific cardiac conditions. The study reported a 49% protective efficacy (odds ratio: 0.51) of antibiotic prophylaxis for first-time episodes of endocarditis within 30 days of procedure. This result was not statistically significant. The quality of the evidence was low. No studies were evaluated on patients with other medical conditions. The recommendations included several cardiac and other medical conditions for which there is a lack of evidence or no evidence to support the use of antibiotic prophylaxis.
There is a lack of evidence to support the use of antibiotic prophylaxis. To avoid the risk of adverse events from antibiotics and the risk of developing resistant bacterial strains, the use of antibiotic prophylaxis should be minimised and recommendations in Sweden should be revised to be more evidence-based.
几乎所有(20 个中的 17 个)瑞典县都设有药剂委员会,负责制定口腔保健中抗生素预防使用的建议。目的是评估口腔保健中抗生素预防使用的证据,以及瑞典建议与证据之间的一致性。
我们在 PubMed 和 Cochrane 对照试验登记处进行了系统的文献检索。在数据库搜索中使用了“抗生素预防”和“牙科”的 MeSH 术语。根据特定的纳入和排除标准,对摘要进行了审查。四位作者独立阅读了 186 篇全文。使用预先确定的方案进行数据提取和解释。最终,纳入了一项病例对照研究来评估证据。
该病例对照研究纳入了具有特定心脏状况的患者。研究报告了抗生素预防在程序后 30 天内首次发生心内膜炎的保护效果为 49%(优势比:0.51)。该结果无统计学意义。证据质量较低。没有评估针对其他医疗条件患者的研究。建议包括几种心脏和其他医疗条件,这些条件缺乏证据或没有证据支持使用抗生素预防。
缺乏支持抗生素预防使用的证据。为避免抗生素不良反应的风险和产生耐药细菌株的风险,应尽量减少抗生素预防的使用,并对瑞典的建议进行修订,使其更具循证依据。